Key result
ECG findings in arrhythmogenic cardiomyopathy help identify early disease and predict VA and SCD risk.
Why the study?
ECG findings may assist in the early recognition of arrhythmogenic cardiomyopathy and identify patients at highest risk for ventricular arrhythmias and sudden cardiac death.
ECG findings are crucial for early recognition and risk stratification of ventricular arrhythmias and sudden cardiac death in patients with arrhythmogenic cardiomyopathy.
ECG findings may aid early recognition and risk stratification in arrhythmogenic cardiomyopathy; hypothesis-generating, requiring prospective validation.
Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and subsequently revised in 2010 and in 2020 by an international task force. According to the last consensus of 2020, ACM is defined as a heart muscle disease affecting right ventricle, left ventricle or both, whose principal pathologic feature is fibrofatty myocardial replacement that impairs systolic ventricular function and predisposes to lethal ventricular arrhythmias. ECG findings not only could help to early recognize affected patients but also could identify the ones with maximum risk of ventricular arrhythmias and sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Calò et al. (2023) conducted a review in Arrhythmogenic cardiomyopathy (ACM). Electrocardiogram (ECG) was evaluated. ECG findings in arrhythmogenic cardiomyopathy can help early recognize affected patients and identify those at maximum risk of ventricular arrhythmias and sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: